MarthaMariePachecoMD
Pediatric Hematology & Oncology • Boise, IDPediatric Hematologic Oncology
Physician
Dr. Pacheco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
St. Luke's Children's Cancer Institute
100 E Idaho St
Boise, ID 83712Phone+1 208-381-2782
Education & Training
University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2006 - 2009- University of Texas Southwestern Medical CenterResidency, Pediatrics, 2003 - 2006
University of Texas Southwestern Medical SchoolClass of 2003
Certifications & Licensure
ID State Medical License 2005 - 2025
TX State Medical License 2005 - 2022- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
- Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Start of enrollment: 2013 Jun 17
- Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Publications & Presentations
PubMed
- 2 citationsBrentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.Christopher J Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia Buhtoiarov, Branko Cuglievan
Blood Advances. 2023-07-11 - 10 citationsHigh risk of relapsed disease in patients with NK/T cell chronic active Epstein-Barr virus disease outside of Asia.Blachy J. Dávila Saldaña, Tami D John, Challice L. Bonifant, David Buchbinder, Sharat Chandra
Blood Advances. 2021-10-20 - 5 citationsAddition of Vincristine and Irinotecan to Standard Therapy in a Patient With Refractory High-risk Hepatoblastoma Achieving Long-term Relapse-free Survival.Jacquelyn M. Powers, Martha Pacheco, Jonathan E. Wickiser
Journal of Pediatric Hematology/oncology. 2019-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
